Zug, Switzerland, 1 May 2018 PSI CRO has opened doors at a new office in the Bay Area. The new property’s location is at 401 California Drive, Burlingame, CA. This way, PSI remains close to Bay Area biotech and pharmaceutical companies while meeting their growth and business needs by expanding into larger, spacious premises. 

Recently, PSI hosted a housewarming event at the new location. “Our presence in the Bay Area continues to be strong. We are rapidly expanding in our offices in Durham and King of Prussia (Philadelphia). We were excited to open our new Burlingame office to the biotech community and invite many of our loyal and new customers to celebrate together the opening of our new home while discussing clinical research challenges,” says Head of North America Operations and California-based team member Tibor Kovacs.

In 2017, PSI CRO announced additional office openings globally, including the purchase of a new premises in Research Triangle Park, Durham NC. The company has also recently opened offices in Taiwan, Korea, and Australia. Since its inception in 1995, PSI has remained a private company fully owned by its founders and has grown organically to include more than 50 locations globally and 2,000+ staff. The company’s further grown in the Bay Area demonstrates the company’s commitment to impacting the greater clinical development landscape of the region.